Added to YB: 2024-05-29
Pitch date: 2024-03-31
KVUE [bullish]
Kenvue Inc.
-13.96%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
Market Cap
$33.2B
Pitch Price
$20.00
Price Target
N/A
Dividend
4.79%
EV/EBITDA
11.47
P/E
23.18
EV/Sales
2.74
Sector
Personal Care Products
Category
value
Show full summary:
Harris Associates U.S. Large Value Strategy New Position: Kenvue Inc.
KVUE: J&J spinoff Kenvue, owner of Neutrogena, Listerine, Tylenol & BandAid, trades at discount to peers despite leading brands. Litigation & share losses cloud near-term, but cost savings can boost R&D/marketing for future growth. Attractive entry point for top consumer health co.
Read full article (1 min)